Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.
The Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
Limiting Access to Tobacco Harm Reduction Products Harms Public Health
The FDA’s decision to stop Juul from selling e-cigarette products in the U.S. will harm public health.
Regulating PBMs Will Not Lower Drug Costs
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
Vaping Saves Lives
Tobacco harm reduction products like e-cigarettes are effective tools that help adults successfully quit smoking.
Unused Cellphones Cost Taxpayers Millions
Mismanagement and a lack of oversight led to the VA wasting taxpayer dollars.
VA/DOD Healthcare Interoperability Can Be Improved
DOD and VA joint OIG report cites problems and makes recommendations to improve interoperability of electronic healthcare records.
Intellectual Property Rights Must Be Protected So the Next Vaccines Can Be Developed
Intellectual property must be protected to encourage the development of future cures.
Virginia Passes Legislation to Extend Cocktails To-Go Until 2024
Cocktails to-go have helped many business stay afloat during the pandemic and Virginia has extended this policy.
President Biden Again Tries to Undermine U.S. Biomedical Innovation
President Biden’s support of intellectual property waivers threatens development of future life-saving medicines.